TNDM Q3 2025 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$249M-31.4% YoY

Gross Profit

$134M53.9% margin

Operating Income

-$20M-8.0% margin

Net Income

-$21M-8.5% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$4M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$875M

Total Liabilities

$742M

Stockholders' Equity

$133M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$249M	$363M	-31.4%
Gross Profit	$134M	$125M	+7.7%
Operating Income	-$20M	-$26M	+23.1%
Net Income	-$21M	-$23M	+9.0%

Revenue Segments

Supplies and Other

$139M56%

Pump

$110M44%

Geographic Segments

UNITED STATES

$176M70%

Non-US

$74M30%